NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-265-2015-0-HK-15 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS HK EP 19100263.9 Issued
NIAID E-135-2010-0-IE-29 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IE EP 19150800.1 Issued
NIAID E-135-2010-0-IT-30 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production IT EP 19150800.1 Issued
NIAID E-135-2010-0-GR-28 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GR EP 19150800.1 Issued
NIAID E-135-2010-0-GB-27 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production GB EP 19150800.1 Issued
NIAID E-135-2010-0-CH-20 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CH EP 19150800.1 Issued
NIAID E-135-2010-0-TR-35 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production TR EP 19150800.1 Issued
NIAID E-135-2010-0-BE-19 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production BE EP 19150800.1 Issued
NIAID E-135-2010-0-AT-18 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production AT EP 19150800.1 Issued
NIAID E-135-2010-0-DK-23 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DK EP 19150800.1 Issued
NIAID E-135-2010-0-CZ-21 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production CZ EP 19150800.1 Issued
NIAID E-135-2010-0-NL-31 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NL EP 19150800.1 Issued
NIAID E-135-2010-0-FR-26 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FR EP 19150800.1 Issued
NIAID E-135-2010-0-DE-22 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production DE EP 19150800.1 Issued
NIAID E-135-2010-0-FI-25 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production FI EP 19150800.1 Issued
NIAID E-135-2010-0-EP-07 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production EP DIV 19150800.1 Issued
NIAID E-135-2010-0-SE-34 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production SE EP 19150800.1 Issued
NIAID E-135-2010-0-PT-33 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production PT EP 19150800.1 Issued
NIAID E-135-2010-0-ES-24 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production ES EP 19150800.1 Issued
NIAID E-135-2010-0-PL-32 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production PL EP 19150800.1 Issued
NIAID E-135-2010-0-NO-36 Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production NO EP 19150800.1 Issued
NCI E-040-2019-0-US-01 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors US 62/789,650 Abandoned
NHLBI E-122-2006-0-US-06 The Discovery Of A Previously Uncharacterized Gene Whose Expression Is Restricted To Renal Cell Carcinoma (RCC) Cells US CON 16/241,017 10557118 Issued PDF
NCATS E-021-2016-0-US-16 Antifungal Compound Process US DIV 16/241,036 10392365 Issued PDF
NCI E-069-2018-1-US-01 Nucleic Acid Nanoparticles (NANP) As Efficient Tools For Controlled Immunomodulation US 62/789,033 Abandoned
NIBIB E-128-2018-1-US-01 SYSTEMS AND METHODS FOR IMPROVED AXIAL RESOLUTION IN MICROSCOPY USING PHOTOSWITCHING AND STANDING WAVE ILLUMINATION TECHNIQUES US 62/789,210 Abandoned
NIDA E-280-2015-0-US-02 GRADIENT COIL WITH EXTERNAL DIRECT COOLING FOR BRAIN MAGNETIC RESONANCE IMAGING US ORD 16/239,747 10739427 Issued PDF
NIAID E-158-2007-3-US-06 Live Attenuated Virus Vaccines for La Crosse Virus and other Bunyaviridae US DIV 16/240,222 10561724 Abandoned PDF
NIAID E-154-2017-0-PCT-02 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE PCT PCT PCT/US2018/068198 Expired
NCI E-767-2013-0-EP-10 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules EP DIV 18215936.8 Pending
NIAID E-154-2017-0-EP-03 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE EP National Stage 18840136.8 Pending
NHLBI E-120-2016-1-CN-02 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE CN National Stage 201780040513.7 Issued
NHLBI E-120-2016-1-KR-06 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE KR National Stage 10-2018-7037984 Issued
NCI E-186-2007-2-US-41 Papillomavirus Pseudoviruses for Detection and Therapy of Tumors US CON 16/235,152 10814014 Issued PDF
NCI E-227-2017-0-PCT-02 METHOD FOR REMOVING PROTEINS AND UNBOUND LABELS FROM EXTRACELLULAR VESICLE PREPARATIONS PCT PCT PCT/US2018/067913 Expired
NHLBI E-120-2016-1-US-08 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE US National Stage 16/313,712 11779603 Issued PDF
NCATS E-190-2016-0-US-08 1 H-PYRAZOL-1-YL-THIAZOLES AS INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US National Stage 16/313,727 10954228 Issued PDF
NIAID E-032-2018-0-PCT-02 Universal Influenza Virus Probes For Enrichment Of Influenza Viral Sequences PCT PCT PCT/US2018/067713 Expired
NCI E-141-2008-0-JP-33 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP DIV 2018-245439 Abandoned
NCI E-230-2012-0-JP-14 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 JP DIV 2018-243703 Issued
NHLBI E-120-2016-1-NZ-10 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE NZ National Stage 749585 Issued
NCATS E-043-2017-3-US-02 Pharmaceutical Compositions With Antiflaviviral Activity US National Stage 16/312,316 1149-11-23 Issued PDF
NIAID E-081-2013-4-AU-14 Prefusion RSV F Proteins And Their Use AU DIV 2018282476 Issued
NICHD E-120-2015-0-US-59 Method For On-demand Contraception US CON 16/230,802 10772897 Issued PDF
NCI E-767-2013-0-EP-09 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules EP DIV 18215053.2 Pending
NIDCD E-004-2019-0-US-01 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY US 62/784,306 Abandoned
NHLBI E-120-2016-1-AU-09 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE AU National Stage 2017286982 Issued
NIAID E-270-2015-0-US-04 Self-assembling Bi-component Nanoparticles For Display Of Coassembled Trimeric Antigens US National Stage 16/312,166 10961283 Issued PDF
NCATS E-189-2016-0-US-03 THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING CANCER US National Stage 16/312,206 10836759 Issued PDF
NIAID E-174-2016-0-US-03 INHIBITOR OF HEME DEGRADATION FOR USE TO IMPROVE ANTIBIOTIC TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTION US National Stage 16/311,876 Abandoned